These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12784122)
21. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter. Kramer HK; Poblete JC; Azmitia EC Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479 [TBL] [Abstract][Full Text] [Related]
22. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain. Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344 [TBL] [Abstract][Full Text] [Related]
23. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat. Mitchell SN; Greenslade RG; Cooper J Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183 [TBL] [Abstract][Full Text] [Related]
24. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Basselin M; Chang L; Bell JM; Rapoport SI Neuropsychopharmacology; 2006 Aug; 31(8):1659-74. PubMed ID: 16292331 [TBL] [Abstract][Full Text] [Related]
25. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Stenfors C; Ross SB Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. He M; Sibille E; Benjamin D; Toth M; Shippenberg T Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590 [TBL] [Abstract][Full Text] [Related]
27. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186 [TBL] [Abstract][Full Text] [Related]
28. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683 [TBL] [Abstract][Full Text] [Related]
29. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies. Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580 [TBL] [Abstract][Full Text] [Related]
30. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Pejchal T; Foley MA; Kosofsky BE; Waeber C Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317 [TBL] [Abstract][Full Text] [Related]
31. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus. Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328 [TBL] [Abstract][Full Text] [Related]
32. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895 [TBL] [Abstract][Full Text] [Related]
33. Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. Li B; Dong L; Wang B; Cai L; Jiang N; Peng L Neurochem Res; 2012 Nov; 37(11):2480-95. PubMed ID: 22711334 [TBL] [Abstract][Full Text] [Related]
34. Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Freo U; Ori C; Dam M; Merico A; Pizzolato G Brain Res; 2000 Jan; 854(1-2):35-41. PubMed ID: 10784104 [TBL] [Abstract][Full Text] [Related]
35. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Bhattacharjee AK; Chang L; Lee HJ; Bazinet RP; Seemann R; Rapoport SI Psychopharmacology (Berl); 2005 Aug; 180(4):735-42. PubMed ID: 16163535 [TBL] [Abstract][Full Text] [Related]
36. Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat. Freo U; Merico A; Ermani M; Ori C Neurosci Lett; 2008 May; 436(2):148-52. PubMed ID: 18387742 [TBL] [Abstract][Full Text] [Related]
37. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system. Volle J; Bregman T; Scott B; Diwan M; Raymond R; Fletcher PJ; Nobrega JN; Hamani C Neuropharmacology; 2018 Jun; 135():63-72. PubMed ID: 29505786 [TBL] [Abstract][Full Text] [Related]
38. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex. Invernizzi R; Bramante M; Samanin R Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551 [TBL] [Abstract][Full Text] [Related]
39. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Hervás I; Artigas F Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863 [TBL] [Abstract][Full Text] [Related]
40. Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18]FDG micro-PET imaging study. Jang DP; Lee SH; Park CW; Lee SY; Kim YB; Cho ZH Neurosci Lett; 2009 Feb; 451(1):60-4. PubMed ID: 19110032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]